SEC Form 4 · accession 0001179110-16-027178
Avalo Therapeutics, Inc. · AVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phil Gutry
Director
Period of report
Jun 30, 2016
Accepted (ET)
Jul 1, 2016 · 3:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534120
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $2.20 | Jun 30, 2016 | A | 1,638 | A | — | Jun 29, 2026 | Common Stock | 1,638 | 1,638 | D |
Explanation of responses
- F1The stock options immediately vested and became exercisable in full upon grant on June 30, 2016.